Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
MBS LABTECH officially launched to sell MBS Capillary Tube designed for biochemistry, immunology, and blood tests in Singapore 2020-11-02 10:00
Investments aim to strengthen capabilities of DuPont(TM) Liveo(TM) healthcare silicone solutions 2020-11-02 09:00
Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development 2020-11-02 08:27
TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000 2020-11-02 07:30
AVATAMED and Macrogen sign MOU on joint business in personalized precision medicine services in cancer treatment 2020-10-30 08:00
AGC Biologics and Horizon Therapeutics plc Expand Partnership 2020-10-30 03:17
ZAGENO Acclaimed by Frost & Sullivan for Simplifying the Biotech Purchasing Process with Its Intuitive eCommerce Platform 2020-10-29 21:00
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide 2020-10-29 20:00
Complete Data from Connect Biopharma's Phase 1b Study of CBP-201 Demonstrate Rapid, Early and Continuous Improvement in Patient Quality of Life and Atopic Dermatitis (AD) Symptoms 2020-10-29 19:00
Kintor Pharmaceutical's COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment 2020-10-29 18:24
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa 2020-10-29 17:00
Deep Longevity and SquareOne Wellness Partner on Deep Biomarkers of Aging and Longevity 2020-10-29 09:57
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia 2020-10-29 09:35
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center 2020-10-29 08:38
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies 2020-10-28 21:00
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition 2020-10-28 07:00
Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab 2020-10-27 21:00
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020-10-27 20:05
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history 2020-10-27 20:00
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
1 272 273 274 275 276 451